Abstract 9: Once-weekly subcutaneous semaglutide 2.4 mg reduces body weight in adults with overweight or obesity regardless of baseline characteristics (STEP 1)

por Suresh, Swaroop H, Kushner, Robert F, Garvey, W Timothy, Hesse, Dan, Koroleva, Anna, Lim, Soo, Lingway, Ildiko, Wallenstein, Ofri Mosenzon Signe O R, Wadden, Thomas A, Roux, Carel W Le
Publicado 2022